Psychology Today1d
Three Ways New Weight Loss Drugs May Improve Depression
The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...
Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea
The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep ...
Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea
Key Takeaways Eli Lilly's Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults with ...
Ars Technica12d
Weight loss drugs may also treat addiction, Alzheimer’s, and heart disease
But there are also ongoing studies in treatment areas with few apparent links to excess ... which is developing an ...
Weight-loss drugs draw Americans back to the doctor
Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...
Medscape4d
New Guidance Recommends Metformin to Prevent Antipsychotic Weight Gain
A new guideline recommends prescribing metformin when initiating an antipsychotic to help mitigate weight gain in certain ...
The American Journal of Managed Care3d
Weight Loss Drug Tirzepatide Now Approved for Sleep Apnea in Adults With Obesity
The approval was based on the results of the SURMOUNT-OSA trial, which found patients had fewer breathing disruptions.
WISH-TV12d
Lilly to test weight loss drug for addiction treatment
Indianapolis-based Lilly says it will test its weight loss drug Zepbound to treat addiction. The weight loss drugs are in a category known as anti-hedonics and could reduce desires for lots of ...
Reuters4d
Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea
Dec 20 (Reuters) - The U.S. Food and Drug Administration on Friday approved Eli Lilly's (LLY.N), opens new tab weight-loss treatment ... Shares of the Indianapolis-based drugmaker were up 1. ...